Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ninghui Hao

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Arxiv|February 6, 2026
Histopathology-centered Computational Evolution of Spatial Omics: Integration, Mapping, and Foundation ModelsNinghui Hao, Xinxing Yang, Boshen Yan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 6, 2024
A Computational and Chemical Design Strategy for Manipulating Glycan-Protein RecognitionQiang Zhu, Didi Geng, Jingchao Li, et al.
Medrxiv : the Preprint Server for Health Sciences|January 20, 2025
Long-term mortality outcomes among immunotherapy recipients treated with dupilumab for the management of cutaneous immune-related adverse eventsSara Khattab, Guihong Wan, Suzanne Xu, et al.
Journal for Immunotherapy of Cancer|May 12, 2025
Long-term mortality outcomes among immunotherapy recipients treated with dupilumab for the management of cutaneous immune-related adverse eventsSara Khattab, Guihong Wan, Suzanne Xu, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Arxiv|February 6, 2026
Histopathology-centered Computational Evolution of Spatial Omics: Integration, Mapping, and Foundation ModelsNinghui Hao, Xinxing Yang, Boshen Yan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 6, 2024
A Computational and Chemical Design Strategy for Manipulating Glycan-Protein RecognitionQiang Zhu, Didi Geng, Jingchao Li, et al.
Medrxiv : the Preprint Server for Health Sciences|January 20, 2025
Long-term mortality outcomes among immunotherapy recipients treated with dupilumab for the management of cutaneous immune-related adverse eventsSara Khattab, Guihong Wan, Suzanne Xu, et al.
Journal for Immunotherapy of Cancer|May 12, 2025
Long-term mortality outcomes among immunotherapy recipients treated with dupilumab for the management of cutaneous immune-related adverse eventsSara Khattab, Guihong Wan, Suzanne Xu, et al.
Pageof 1